The Board of Directors of the Company at their meeting held on Today i.e., 25th MMay, 2026 has recommended the Final Dividend of Rs. 3/- per share (30% of the Face Value) on the Equity ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.9 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved FY2026 standalone results showing revenue of Rs. 20,312.55 lakhs (up 122% from Rs. 9,137.99 lakhs), but PAT declined to Rs. 5,630.56 lakhs from Rs. 9,411.91 lakhs (down 40%). The auditors issued unmodified opinions. Key decisions include recommending Rs. 3 per share dividend (30% on face value), expanding the Main Object Clause to include new products like Ethanol and pharmaceuticals, shifting registered office from Gujarat to Haryana, and appointing J S Varma & Co as internal auditor. Notable concerns: PAT fell sharply despite massive revenue growth, Rs. 2,784.33 lakh impairment on Paper Division discontinued operations, and the company remains restrained from securities markets per SAT/Supreme Court orders.
The 122% revenue surge was overshadowed by 40% PAT decline, signalling severe margin compression. The securities market restraint and impairment losses add to investor concerns, though the dividend offers limited upside.